Prof. Dr. Volkan İzol

Estetik Plastik ve Rekonstrüktif Cerrahi Uzmanı

Özgeçmiş

Prof. Dr. Volkan İzol’un 2002 yılında Çukurova Üniversitesi Tıp Fakültesi’nden Tıp Doktoru ve 2008 yılında Çukurova Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı’ndan Üroloji Uzmanı unvanını almıştır.

Aynı Anabilim Dalı’nda 2011 yılında öğretim üyesi olarak görev yapmaya başlamış ve 16 Nisan 2015 tarihinde doçent, 28 Ağustos 2020’de profesör unvanını almıştır. Asistanlık döneminde Avrupa Üroloji Diplomasını almaya hak kazanan İzol, uzmanlık sonrası dönemde ise minimal invaziv cerrahide bilgi ve tecrübesini artırmak üzere John Hopkins Üniversitesi’nde (ABD) gözlemci statüsünde çalışmıştır.

Uluslararası ve Ulusal hakemli dergilerde yayımlanan birçok makalesi mevcut olan İzol’un yurt dışı-yurt içi bilimsel toplantıda 200’ün üzerinde sözlü bildirisi ve konuşması bulunmaktadır. Günlük pratiğinde sıklıkla Üroonkoloji ve minimal invaziv ürolojik cerrahi ile ilgilenmektedir.

Bilimsel çalışmalar

  1. A. Arıdoğan, A. Ateş, V. Izol, M. İlkit, “Tinea cruris in routine urology practice”, Urologia Internationalis, “74(4)”, 346-348 pp., Mayıs-2005, DOI: 10.1159/000084436, İlgili atıf indekslerince taranıyor.
  2. İ.A. Arıdoğan, M. İlkit, V. Izol, A. Ateş, “Malassezia and Candida colonization on glans penis of circumcised men”, Mycoses, “48(5)”, 352-356 pp., Eylül-2005, İlgili atıf indekslerince taranıyor.
  3. İ.A. Arıdoğan, M. İlkit, V. Izol, A. Ateş, H. Demirhindi, “Glans penis and prepuce colonisation of yeast fungi in a paediatric population: pre- and postcircumcision results”, Mycoses, “52(1)”, 49-52 pp., Ocak-2009, DOI: 10.1111/j.1439-0507.2008.01535.x, İlgili atıf indekslerince taranıyor.
  4. İ.A. Arıdoğan, V. Izol, M. İlkit, “Superficial fungal infections of the male genitalia: a review”, Critical Reviews in Microbiology, “37(3)”, 237-244 pp., Ağustos-2011, DOI: 10.3109/1040841X.2011.572862, İlgili atıf indekslerince taranıyor.
  5. Izol, B. Soyupak, G. Seydaoglu, İ.A. Arıdoğan, Z. Tansuğ, “Three different techniques for administering analgesia during transrectal ultrasound-guided prostate biopsy: a comparative study”, International Braz J Urol , “38(1)”, 122-128 pp., Ocak-2012, İlgili atıf indekslerince taranıyor.
  6. Çelik, İ.A. Arıdoğan, V. Izol, S. Erdoğan, S. Polat, Ş. Doran, “An Evaluation of the Effects of Long-Term Cell Phone Use on the Testes via Light and Electron Microscope Analysis”, Urology, “79(2)”, 346-350 pp., Şubat-2012, DOI: 10.1016/j.urology.2011.10.054, İlgili atıf indekslerince taranıyor.
  7. Mammadov, İ.A. Aridogan, V. İzol, A. Açıkalın, D. Abat, A. Tuli, Y. Bayazıt, “The protective effects of phosphodiesterase-4-specific inhibitor Rolipram on acute ischemia-reperfusion injury in rat kidney”, Urology, “80(6)”, 1390-1396 pp., Aralık-2012, DOI: 10.1016/j.urology.2012.07.028, İlgili atıf indekslerince taranıyor.
  8. Izol, A. Eken, I.A. Arıdoğan, S. Koltas, Z. Tansug, “Acute urinary retention due to cystic echinococcosis: A case report”, Canadian Urological Association Journal, “6(5)”, 192-194 pp., Ekim-2012, DOI: 10.5489/cuaj.11154, İlgili atıf indekslerince taranıyor.
  9. Eken, V. Izol, İ.A. Arıdoğan, Ş. Erdoğan, A. Açıkalın, Z. Tansuğ, “An unusual cause of hematospermia: Primary adenocarcinoma of the seminal vesicle”, Canadian Urological Association Journal, “6(6)”, 259-262 pp., Aralık-2012, DOI: 10.5489/cuaj.11132, İlgili atıf indekslerince taranıyor.
  10. İ.A. Aridogan, V. Izol, D. Abat, O. Karslı, Y. Bayazıt, N. Satar, “Epidemiological characteristics of Fournier’s Gangrene: A report of 71 patients”, Urologia Internationalis, “89(4)”, 457-461 pp., Ekim-2012, DOI: 10.1159/000342407, İlgili atıf indekslerince taranıyor., Endeks: SCI-Expanded
  11. Karsli, V. İzol, İ.A. Aridogan, A. Borekoglu, N. Satar, “Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia”, Urolithiasis, “41(1)”, 9-13 pp., Şubat-2013, DOI: 10.1007/s00240-012-0539-2, İlgili atıf indekslerince taranıyor., Endeks: SCI
  12. Tashbulatova, İ.A. Arıdoğan, V. Izol, G. Şeydaoğlu, İ.F. Ürünsak, Ş. Doran, “İnfertil kadınlarda cinsel fonksiyon bozukluğu: depresyon ve demografik faktörler ile ilişkisi”, Turkiye Klinikleri Journal of Medical Sciences, “33(1)”, 91-97 pp., Şubat-2013, DOI: 10.5336/medsci.2012-28503, İlgili atıf indekslerince taranıyor.
  13. Sah, İ.A. Arıdoğan, V. Izol, S. Erdoğan, S. Doran, “Effects of Long-Term Administration of The Anti-Aging Hormone Dehydroepiandrosterone-Sulfate on Rat Prostates and Testes as Androgen-Dependent Organs”, Korean Journal of Urology, “54(3)”, 199-203 pp., Mart-2013, DOI: 10.4111/kju.2013.54.3.199, İlgili atıf indekslerince taranıyor.
  14. Izol, İ.A. Arıdoğan, O. Karsli, M. Deger, N. Satar, “The effect of prophylactic treatment with Shohl’s solution in children with cystinuria”, Journal of Pediatric Urology , “9(6 Pt B)”, 1218-1222 pp., Aralık-2013, DOI: 10.1016/j.jpurol.2013.05.017, İlgili atıf indekslerince taranıyor.
  15. Onal, H.S. Dogan, N. Satar, C.Y. Bilen, A. Güneş, E. Ozden, A. Ozturk, D. Demirci, O. Istanbulluoğlu, S. Gurocak, O. Nazli, O. Tanriverdi, A. Kefi, E. Korgali, M.S. Silay, K. Inci, V. Izol, R. Altintas, H. Kilicarslan, S. Sarikaya, V. Yalcin, C. Aygun, F. Gevher, I.A. Aridogan, S. Tekgul, “Factors affecting complication rates of percutaneous nephrolithotomy in children: results of multi-institutional retrospective analysis by Pediatric Stone Disease Study Group of Turkish Pediatric Urology Society”, The Journal of Urology, “191(3)”, 777-782 pp., Mart-2014, DOI: 10.1016/j.juro.2013.09.061, İlgili atıf indekslerince taranıyor.
  16. Izol, A. Acikalin, Y. Kuyucu, M. Deger, I.A. Aridogan, S. Polat, N. Satar, “Ultrastructural and Immuno-Histopathological Evaluation of Intravesical Ureters via Electron and Light Microscopy in Children with Vesicoureteral Reflux.”, The Journal of Urology, “191(4)”, 1110-1117 pp., Nisan-2014, DOI: 10.1016/j.juro.2013.10.038, İlgili atıf indekslerince taranıyor., Endeks: SCI
  17. Erdogan, A. Acikalin, H. Zeren, G. Gonlusen, S. Zorludemir, V. Izol, “Well differentiated papillary mesothelioma of the tunica vagınalis: case report and review of the literature”, The Korean Journal of Pathology, “48”, 225-228 pp., Haziran-2014, DOI: 10.4132/KoreanJPathol.2014.48.3.225.
  18. Demir, V. Izol, I.A Aridogan, S. Paydas, Z. Tansug, U. Erken, “Immediate and long-term high levels of plasma homocysteine after extracorporeal shock wave lithotripsy in patients with renal stone disease”, Clinical and Experimental Nephrology, “18(4)”, 623-625 pp., 2014, DOİ: 10.1007/s10157-013-0884-7.
  19. T. Akcam, A. Ulku, I.S. Koltas, V. Izol, O.S. Bicer, E. Kilicbagir, G. Sakman, H. Poyrazoglu, T. Erman, I.A. Aridogan, C.K. Parsak, M. Inal, S. Iskit, “Clinical characterization of unusual cystic echinococcosis in southern part of Turkey”, Annals of Saudi Medicine, “34(6)”, 508-516 pp., 2014, DOİ: 10.5144/0256-4947.2014.508.
  20. Izol, I.A. Aridogan, A. Borekoglu, F. Gokalp, Z. Hatipoglu, Y. Bayazit, S. Zeren, “Percutaneous nephrolithotomy in prone position in patients with spinal deformities”, International Journal of Clinical and Experimental Medicine, “8(11)”, 21053-21061 pp., 2015.
  21. M. Kaplan, V. Izol, I.A. Aridogan, E. Olgan, A.A. Yegani, P. Pazarci and E. Şingirik, Protective Effect of Hypericum perforatum Extract on Gentamicin Induced Nephrotoxicity in Mice. International Journal of Pharmacology, 12(5), 562-566 pp., 2016, DOI: 10.3923/ijp.2016.663.668
  22. M. Kaplan, V. İzol, İ.A. Aridogan, E. Olgan, A.A. Yegani, P. Pazarcı and E. Şingirik, Protective Effect of Alpha-linolenic Acid on Gentamicin Induced Nephrotoxicity in Mice. International Journal of Pharmacology, 12(6), 663-668 pp., 2016, DOI: 10.3923/ijp.2016.562.566
  23. Karlidag, D. Abat, A. Altunkol, V. Izol, E. Demir, I.A. Aridogan, Is the Homocysteine Level a Good Predictive Marker for Evaluating Kidney Function in Patients After Percutaneous Nephrolithotomy?, Urology Journal, 2018 Jan 4. DOI: 10.22037/uj.v0i0.3917.
  24. Hatipoglu, E. Gulec, M. Turktan, V. Izol, ı.A. Aridogan, Y. Gunes, D. Özcengiz, Comparative Study Of Ultrasound-Guided Paravertebral Block Versus İntravenous Tramadol For Postoperative Pain Control İn Percutaneous Nephrolithotomy, BMC Anesthesiology, 18(24), 1-6 pp., 2018, DOI 10.1186/s12871-018-0479-7.
  25. Deger, V. Izol, F. Gokalp, Y. Bayazit, I. A. Aridogan, Z.Tansug, Evaluation of Concordance between Gleason Scores of Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Samples in Prostate Cancer, Journal of Analytical Oncology, 7(1), 8-13pp., 2018.
  26. Izol, F. Gokalp, O. Karslı, E. Kaplan, M. Deger, A. Aridogan, Z. Tansug, Laparoscopic marsupialization of pelvic lymphoceles following radical prostatectomy, International Surgery Journal, 5(6), 2027-2030pp.,  2018,  DOI:10.18203/2349-2902.isj20182213.
  27. Kaygısız, F. A. Türegün, N. Satar, E, Özen, S. Toksöz, H. S. Doğan, M. M. Pişkin, V. İzol, Ş. Sarıkaya, H. Kılıçarslan, T. Çiçek, A. Öztürk, S. Tekgül, B. Önal, Renal stone composition does not affect the outcome of percutaneous nephrolithotomy in children, World Journal of Urology, 2018, DOI: 10.1007/s00345-018-2325-4.
  28. Kaygısız, N. Satar, A. Güneş, HS. Doğan, A. Erözenci, E. Özden, MM. Pişkin, D. Demirci, S. Toksöz, Çiçek T, Gürocak S, H.  Kılıçarslan, O. Nazlı, A. Kefi, V. İzol, A. Beytur, Sarıkaya Ş, Tekgül S, Önal B, “Factors predicting postoperative febrile urinary tract infection following percutaneous nephrolithotomy in prepubertal children”,Journal of Pediatric Urology,  pii: S1477-5131(18)30179-7, 2018. DOI: 10.1016/j.jpurol.2018.04.010.
  29. Akdogan, F. Gokalp, V. Izol, N. Satar, “Ureteral Triplication Associated With Upper Pole Ureteropelvic Junction Stenosis”, Journal of Medical Cases, 9(7), 195-197 pp., 2018. doi: https://doi.org/10.14740/jmc3060w.
  30. Izol, Y. Kuyucu, A. Acikalin, M. Deger, I.A. Aridogan, S. Polat, N. Satar, “Evaluation of the intravesical ureters after failed endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid in children via light and transmission electron microscopic analysis. A Matched Case-Control Study”, Urology Journal, doi: 10.22037/uj.v0i0.4281. 2019
  31. Borekoglu, I. A. Arıdogan, M. Deger, O. Karslı, V. Izol, “Comparison of the results of percutaneous nephrolithotomy in different age groups”, International Surgery Journal, 5(12), 2018, DOI: 10.18203/2349-2902.isj20180001.
  32. İzol, I. A. Arıdoğan, Z. Tansuğ, F. Doran, K. Erdoğan, H. M. Kaplan, E. Şingirik, P. Ertuğ, P. Pazarci, “Hypericum perforatum Extract Against Oxidative Stress, Apoptosis and Oedema in Kidney Induced by Gentamicin”, International Journal of Pharmacology, 15(1), 66-73 pp., 2019, DOI: 10.3923/ijp.2019.
  33. Andıç, V. Izol, S. Gokcay, H.S. Arslantas, Y. Bayazit, H. Coskun, M. Z. Tansug, Y. Sertdemir, “Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study”, BMC Urology, 2019, 19:3, DOI: 10.1186/s12894-018-0432-6
  34. Izol, M. Deger, B. Kizilgok, I.A. Aridogan, M.Z. Tansug, “Management of erosion of inflatable penile prosthesis reservoir into bladder. A different approach”, Archivio Italiano di Urologia e Andrologia, 2019, 9;91(1), 43-45 pp, DOI: 10.4081/aiua.2019.1.43
  35. Akkus, I.B. Güney, F. Ok, M. Evran, V. Izol, S. Erdoğan, Y. Bayazit, M. Sert, T. Tetiker, “Diagnostic efficacy of 18F-FDG PET/CT in patients with adrenal incidentaloma.”, Endocrine Connections, 2019, DOI: 10.1530/EC-19-0204.
  36. Izol, M.Deger, M.Z.Tansug, “Vena cava defect repair using a polytetrafluoroethylene graft after a radical nephrectomy and vena cava resection: A case report”, Archivio Italiano di Urologia e Andrologia 2019 DOI: 10.4081/aiua.2019.3.
  37. İ.B. Güney, K.A. Küçüker, V. İzol, M. Kibar, “The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma.”, Turk J Urol. 2019 Nov 1;45(6):423-430. doi: 10.5152/tud.2019.84453
  38. Zümrütbas AE, Citgez S, Acar Ö, İzol V, Uzun H, Kabay Ş, Sancak EB, Yazıcı C, Erdogan MS, Tarcan T, Demirkesen O, “The real-life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short-term outcome.”, Neurourol Urodyn. 2019 Nov;38(8):2170-2177. doi: 10.1002/nau.24079.
  39. Deger, V. Izol, MZ. Tansuğ. ‘’Lokalize Böbrek Tümörlerinde Nefron Koruyucu Cerrahi’’Çukurova Anestezi ve Cerrahi Bilimler Dergisi Cilt 2, Sayı 2, 81-88,2019
  40. Çelik, G. Aslan, S. Sözen, H. Özen, B. Akdoğan, S. Baltaci, V. İzol, Z. Tansuğ, L Türkeri, ‘Factors Affecting Surgical Margin Positivity after Radical Prostatectomy in the Turkish Population: A Multicenter Study of the Urooncology Association.’ Urologia Internationalis, 2020 Apr 30:1-7. doi: 10.1159/000507268.
  41. Tinay I, Ozden E, Suer E, Bozkurt O, Izol V, Sahin B, Turkeri L. The Early Impact of COVID-19 Pandemic on Surgical Urologic Oncology Practice in Turkey: Multi-Institutional Experience From Different Geographic Areas Urology. 2020 May 20:S0090-4295(20)30567-7. doi: 10.1016/j.urology.2020.05.016.
  42. Deger, V. Izol, A. Acikalin, Y. Kuyucu, I.A. Aridogan, S. Polat, N. Satar. Comparison Of The Cytokine Profiles And Ultrastructural Changes In The Ureterovesical Junctions Of Children With Primary Vesicoureteral Reflux And Children With Primary VUR Following Failed Injection Therapy With Dx/HA. / Sayfalar Çukurova Anestezi ve Cerrahi Bilimler Dergisi Cilt 3, Sayı 1: 33-45
  43. Acikalin A, Bagir E, Karim Savalan, Bisgin A, Izol V, Erdogan S. Primary Melanoma of the Urinary Tract; Clinicopathologic and Molecular Review of a Case Series. Pathology – Research and PracticenAvailable online 29 June 2020, 153095
  44. Sen V, Eren H, Kazaz IO, Goger YE, Izol V, Tarhan H, Argun B, Akbal C, Mungan A, Esen AA. Easily accessible, up-to-date and standardised training model in Urology: E-Learning Residency training programme (ERTP). Int J Clin Pract. 2020 Aug 18:e13683. doi: 10.1111/ijcp.13683. Epub ahead of print. PMID: 32810325.
  45. Haberal HB, Gudeloglu A, Deger M, Gulsen M, Izol V, Bostanci Y, Aridogan A, Ozden E, Bilen CY. Percutaneous Nephrolithotomy in Young-Old, Old-Old, and Oldest-Old Patients: a Multicenter Study. J Laparoendosc Adv Surg Tech A. 2020 Sep 21. doi: 10.1089/lap.2020.0537. Epub ahead of print. PMID: 32955989.
  46. Akkus G, Izol V, Ok F, Evran M, Inceman M, Erdogan S, Kaplan HM, Sert M, Tetiker T. Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus. Int J Clin Pract. 2020 Sep 21:e13723. doi: 10.1111/ijcp.13723. Epub ahead of print. PMID: 32957168.
  47. Deger M, Surmelioglu O, Kuleci S, Izol V, Akdogan N, Onan E, Tanrısever I, Aridogan IA. Risk Factors Associated with Nocturia in Patients with Obstructive Sleep Apnea Syndrome. Int J Clin Pract. 2020 Sep 21:e13724. doi: 10.1111/ijcp.13724. Epub ahead of print. PMID: 32959453.
  48. Bozkurt O, Sen V, Irer B, Sagnak L, Onal B, Tanidir Y, Karabay E, Kaya C, Ceyhan E, Baser A, Duran MB, Suer E, Celen I, Selvi I, Ucer O, Karakoc S, Sarikaya E, Ozden E, Deger D, Egriboyun S, Ongun S, Gurboga O, Asutay MK, Kazaz IO, Yilmaz IO, Kisa E, Demirkiran ED, Horsanali O, Akarken I, Kizer O, Eren H, Ucar M, Cebeci OO, Kizilay F, Comez K, Mercimek MN, Ozkent MS, Izol V, Gudeloglu A, Ozturk B, Akbaba KT, Polat S, Gucuk A, Ziyan A, Selcuk B, Akdeniz F, Turgut H, Sabuncu K, Kaygisiz O, Ersahin V, Ibrahim Kahraman H, Guzelsoy M, Demir O; Study Group of the Society of Urological Surgery. Nation-wide analysis of the impact of Covid-19 pandemic on daily urology practice in Turkey. Int J Clin Pract. 2020 Sep 30:e13735. doi: 10.1111/ijcp.13735. Epub ahead of print. PMID: 32996259; PMCID: PMC7536952.
  49. Gokalp, F, Izol V, Deger M, Erkoc M, Alptekin D, Satar N. Evaluation of exon-1 HOX-B7 mutations in Turkish reflux nephropathy patients. Genet. Mol. Res. 19(3): GMR18578DOI: 4238/gmr18578
  50. Aslan G, Çelik S, Sözen S, Akdoğan B, İzol V, Bilen CY, Sahin B, Türkeri L; Members of Urooncology Association. Comparison of TRUS and Combined MRI Targeted plus Systematic Prostate Biopsy for the Concordance Between Biopsy and Radical Prostatectomy Pathology. Int J Clin Pract. 2020 Oct 28:e13797. doi: 10.1111/ijcp.13797. Epub ahead of print. PMID: 33113261.
  51. Izol V, Deger M, Baltaci S, Akgul M, Selvi İ, Ozden E, Süer E, Zuhtu Tansug M; Bladder Cancer Study Group of Association of Urooncology, Turkey. The Effect of Body Mass Index on Oncological and Surgical Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Multicenter Study of the Association of Urooncology, Turkey. Int J Clin Pract. 2020 Oct 8:e13750. doi: 10.1111/ijcp.13750. Epub ahead of print. PMID: 33090610.
  52. Izol V, Deger M, Akdogan N, Ok F, Bayazit Y, Aridogan IA. The Effect of Percutaneous Nephrolithotomy on the Estimated Glomerular Filtration Rate in Patients with Chronic Kidney Disease. J Endourol. 2020 Nov 11. doi: 10.1089/end.2020.0512. Epub ahead of print. PMID: 33054416.
  53. Tinay İ, Baltaci S, Demirdag C, Akdogan B, Yucetas U, Fatih Simsekoglu M, Bahadır Haberal H, Bozlu M, Izol V, Aslan G, Bekiroğlu N. Ta Grade 3/High Grade Non-Invasive Bladder Cancer: Should We Perform A Second TUR? Int J Clin Pract. 2020 Dec 10:e13924. doi: 10.1111/ijcp.13924. Epub ahead of print. PMID: 33300226.
  54. Akdogan N, Aridogan I, Izol V, Deger M, Gokalp F, Bayazit Y, Tansug M. Use of the prostate health index in the detection of prostate cancer at all PSA levels. Int J Clin Pract. 2020 Dec 10:e13922. doi: 10.1111/ijcp.13922. Epub ahead of print. PMID: 33300224.
  55. Izol V, Satar N, Bayazit Y, Gokalp F, Akdogan N, Aridogan IA. Which factors affect the success of pediatric PCNL? Single center experience over 20 years. Arch Ital Urol Androl. 2020 Dec 18;92(4). doi: 10.4081/aiua.2020.4.345. PMID: 33348964.
  56. Izol V, Gokalp F, Sozen S, Ozden E, Bayazit Y, Muezzinoglu T, Kara O, Cetin S, Gulsen M, Turkeri L, Zuhtu Tansug M; Kidney Cancer Study Group of Urooncology Association, Turkey. Factors affecting long-term renal functions after partial vs radical nephrectomy for clinical T1 renal masses: A Multicentre Study of the Urooncology Association, Turkey. Int J Clin Pract. 2021 Jan 4:e13960. doi: 10.1111/ijcp.13960. Epub ahead of print. PMID: 33394541.
  57. Çelik S, Kızılay F, Yörükoğlu K, Özen H, Akdoğan B, İzol V, Bayazıt Y, Aslan G, Sözen S, Baltacı S, Müezzinoğlu T, Narter F, Türkeri L. Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-Core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey. Bull Urooncol 2021;20(1):19-25.
  58. İzol V, Deger M, Ozden E, Bolat D, Argun B, Baltaci S, Celik O, Akgul HM, Tinay İ, Bayazit Y; Bladder Cancer Study Group of Association of Urooncology, Turkey. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma. Urol Int. 2021;105(3-4):291-297. doi: 10.1159/000511650. Epub 2020 Dec 2. PMID: 33264798.
  59. Ziyadov E, Bisgin A, Deger M, Akdogan N, Izol V, Aridogan IA, Satar N. Determination of the etiology of pediatric urinary stone disease by multigene panel and metabolic screening evaluation. J Pediatr Urol. 2021 Apr 1:S1477-5131(21)00181-9. doi: 10.1016/j.jpurol.2021.03.028. Epub ahead of print. PMID: 33896740.
  60. Izol V, Akdoğan N, Özen H, Akdoğan B, Kural AR, Tuna MB, Sözen S, Türkeri L, Tansuğ MZ; Members of Urooncology Association, Turkey. The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey. Int J Clin Pract. 2021 Apr 29:e14281. doi: 10.1111/ijcp.14281. Epub ahead of print. PMID: 33914398.
  61. Çelik S, Kızılay F, Yörükoğlu K, Aslan G, Ozen H, Akdogan B, Sozen S, Baltaci S, Muezzinoglu T, Izol V, Bayazıt Y, Narter F, Türkeri L; Members of Turkish Urooncology Association. Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey. Urol Int. 2021 May 5:1-9. doi: 10.1159/000513658. Epub ahead of print. PMID: 33951662.
  62. Tokat E, Gurocak S, Ozkan S, Dogan HS, Citamak B, Satar N, Izol V, Deger M, Sarikaya S, Bostanci Y, Gulsen M, Onal B, Altinay Kirli E, Burgu B, Soygur T, Haciyev P, Agras K, Karabulut B, Akbal C, Akin Sekerci C, Demirci D, Baydilli N, Tekgul S, Ozgur Tan M. Clinical practice in vesicoureteral reflux with respect to EAU guidelines: A multicenter study. Int J Clin Pract. 2021 May 9:e14339. doi: 10.1111/ijcp.14339. Epub ahead of print. PMID: 33966353.
  63. Ucer O, Muezzinoglu T, Ozden E, Aslan G, Izol V, Bayazit Y, Altan M, Akdogan B, Ozen H, Sozen S, Cetin S, Suer E, Esen B, Baltaci S; Members of Urooncology Association. How accurate is radiological imaging for perirenal fat and renal vein invasion in renal cell carcinoma? Int J Clin Pract. 2021 May 11:e14359. doi: 10.1111/ijcp.14359. Epub ahead of print. PMID: 33974338.
  64. Deger M, Ozmen C, Akdogan N, Tepe O, Yucel SP, Izol V. The Relationship Between Gensini Score and Erectile Dysfunction in Patients with Chronic Coronary Syndrome. Sex Med. 2021 Jun 2;9(3):100376. doi: 10.1016/j.esxm.2021.100376. Epub ahead of print. PMID: 34090241.
  65. Deger M, Akdogan N, Izol V, Kaplan HM, Pazarci P, Arıdogan IA. Protective effect of naringin in rat model of renal ischemia reperfusion injury. REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 41(2),113-118.
  66. Karkin K, İzol V, Kaplan M, Değer M, Akdoğan N, Tansuğ MZ. Demonstration of advanced glycation end product (AGE) expression in bladder cancer tissue in type-2 diabetic and non-diabetic patients and the relationship between AGE accumulation and endoplasmic reticulum stress with bladder cancer. Int J Clin Pract. 2021 Oct;75(10):e14526. doi: 10.1111/ijcp.14526. Epub 2021 Jun 26. PMID: 34120398.
  67. Kuyucu Y, Coşkun G, Şaker D, Karaoğlan Ö, Ürünsak İF, İzol V, Arıdoğan İA, Erdoğan Ş, Özgür H, Polat S. Immunohistochemical examination of androgen receptor and estrogen receptor alpha expressions in obstructive and non-obstructive azoospermia. Syst Biol Reprod Med. 2021 Aug 22:1-8. doi: 10.1080/19396368.2021.1958094. Epub ahead of print. PMID: 34420467.
  68. Suer E, Akpinar C, Izol V, Bayazit Y, Sozen S, Cetin S, Ozden E, Turkeri L, Bozkurt O, Ucer O, Baltaci S. Predicting factors of acute kidney injury after partial nephrectomy and its impact on long-term renal function: A multicentre study of the Turkish Urooncology Association. Int J Clin Pract. 2021 Aug 24:e14751. doi: 10.1111/ijcp.14751. Epub ahead of print. PMID: 34431175.
  69. Deger M, Surmelioglu O, Kuleci S, Akdogan N, Dagkiran M, Tanrisever I, Yucel SP, Izol V. The effect of treatment of obstructive sleep apnea syndrome on overactive bladder symptoms. Rev Assoc Med Bras (1992). 2021 Mar;67(3):360-365. doi: 10.1590/1806-9282.20200607. PMID: 34468598.
  70. Deger M, Kaya B, Akdogan N, Kaplan HM, Bagir E, Izol V, Aridogan IA. Protective effect of dapagliflozin against cyclosporine A-induced nephrotoxicity. Drug Chem Toxicol. 2021 Sep 27:1-7. doi: 10.1080/01480545.2021.1979996. Epub ahead of print. PMID: 34565275
  71. Izol V, Ok F, Aslan G, Akdogan B, Sozen S, Ozden E, Celik O, Muezzinoglu T, Turkeri L, Akdogan N, Baltaci S. Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association. Prostate. 2022 Feb 21. doi: 10.1002/pros.24318. Epub ahead of print. PMID: 35188993.
  72. İzol, B. Soyupak, “Travmatik Olmayan Nörojenik İşeme Bozuklukları”, Turkiye Klinikleri Journal of Surgical Medical Sciences, “1(5)”, 43-48 pp., 2005
  73. İ.A. Arıdoğan, V. İzol, “Erektil Disfonsiyonda İkinci Basamak Tedavi”, Turkiye Klinikleri Journal of Surgical Medical Sciences , “3(38)”, 34-37 pp., 2007
  74. İ.A. Arıdoğan, V. İzol, “Her nokturi benign prostat hiperplazisine mi bağlıdır?”, Turkiye Klinikleri Journal of Urology-Special Topics , “1(2)”, 112-114 pp., 2008
  75. Karslı, V. İzol, İ.A. Arıdoğan, “Pelvik cerrahi sonrası görülen ürolojik sorunlar”, Androloji Bülteni , “43”, 251-253 pp., 2010
  76. İzol, B. Soyupak, “Metastatik renal hücreli karsinomda cerrahi yaklaşım”, Üroonkoloji Bülteni , “3”, 36-40 pp., 2011
  77. İzol, E. Demir, “Transrektal Ultrason Kılavuzluğunda Uygulanan Prostat Biyopsisinde Dünden Bugüne”, Türk Üroloji Seminerleri , “2”, 232-235 pp., 2011
  78. İzol, B. Hüseynov, İ.A. Arıdoğan, “Prostatit tedavisinde güncel yaklaşımlar”, Archives Medical Review Journal , “22(1)”, 130-140 pp., 2013
  79. İzol, N. Satar, “Üreteropelvik ve Üreterovezikal Bileşke Anatomisi ve Fizyolojisi”, Turkiye Klinikleri Journal of Urology-Special Topics , “6(1)”, 1-7 pp., 2013
  80. V, İzol, M. Değer, “Stres Tip İdrar Kaçırmada Kök Hücre Tedavisi”, Kadın ve İşlevsel Üroloji Bülteni , “3(1)”, 10-14 pp., 2013
  81. İzol, M. Değer, İ.A. Arıdoğan,, “Erkek Kontrasepsiyon Yöntemleri”, Androloji Bülteni , “53”, 117-121 pp., 2013
  82. A. Açıkalın, Ş. Erdoğan, E. Bağır, V. Izol, Z. Tansuğ, G. Şeydaoğlu, S. Zorludemir, G. Gönlüşen,  “Evaluation of C-ErbB-2 Expression, Amplification and Prognostic Value in Primary and Metastatic Prostate Adenocarcinomas”, Erciyes Medical Journal, “36(4)”, 156-160 pp., 2014
  83. İzol, E. Kaplan, “Renal Hücreli Kanserde Paraneoplastik Sendromlar”, Üroonkoloji Bülteni, “13(3)”, 135-138 pp., 2014
  84. İzol, C. Baran, “Böbrek kanserlerinde acil durumlar”, Kanser Gündemi Dergisi, “3(2)”, 94-96 pp., 2015
  85. İzol, Ali Börekoğlu, “Pediatrik Üriner Sistem Taş Hastalığı”, Turkiye Klinikleri J Urology-Special Topics, “8(4)”, 24-28 pp, 2015
  86. Gökalp, V. İzol, “Laparoskopik Pyeploplasti”, Turkiye Klinikleri J Urology – Special Topics, “9(3)”, 64-69 pp, 2016
  87. Karslı, V. İzol, “Benign prostat hiperplazisi ve mesane taşı birlikteliğinde perkütan ve transüretral sistolitotripsinin karşılaştırılması”, Cukurova Med J, “41(4)”, 709-713 pp., 2016, DOI: 10.17826/cutf.254202
  88. E Bağır, A. Açıkalın, V. İzol, G. Şeydaoğlu, Ş. Erdoğan, “Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis”, Bulletin of Urooncology “15”, 144-147 pp., 2016, DOI: 10.4274/uob.708
  89. İzol, N.Akdoğan, “Konjenital Genital Bölge Malformasyonları: Mikropenis”,  Turkiye Klinikleri J Plast Surg-Special Topics “5(3)”, 26-29 pp., 2016
  90. Karslı, V. İzol, “Konjenital Genital Bölge Malformasyonları: Mikropenis Rekonstrüksiyonu”, Turkiye Klinikleri J Plast Surg-Special Topics “5(3)”, 30-34 pp., 2016
  91. İzol, N.Akdoğan, “Prostat Kanserinde Aktif İzlem”, Bulletin of Urooncology “16”,  pp., 127-132, 2017, DOI: 10.4274/uob.820
  92. Kızılgök, V. İzol, E. Erken, M.Z. Tansuğ, “A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis” , Bulletin of Urooncology “17” , 33-35 pp., 2018; DOI: 10.4274/uob.915
  93. Gökalp, M. Değer, V. İzol, “Prematür Ejakülasyonda Güncel Tedavi Yaklaşımları”, Journal of Cukurova Anesthesia and Surgical Sciences, “1: 1”, 10-13 pp., 2018
  94. Deger, V. Izol, MZ. Tansuğ. ‘’Lokalize Böbrek Tümörlerinde Nefron Koruyucu Cerrahi’’Çukurova Anestezi ve Cerrahi Bilimler Dergisi Cilt 2, Sayı 2, 81-88,2019
  95. Deger, V. Izol, F Ok, Y. Bayazıt, N. Satar, I.A. Aridogan. ‘’The Comparıson Of Effıcacy And Safety Of Isolated Sıngle Dıfferent Calyx Accesses In Percutaneous Nephrolıthotomy.’’ Journal of Urological Surgery, 2019;6(4):289-294 Doi: 10.4274/jus.galenos.2019.2858
  96. İzol V., Kızılgök B., Değer M., Bayazıt Y., Tansuğ M.Z. The effect of tumor localization and clinicopathological factors on intravesical recurrence and survival in primary upper urinary tract urothelial tumors. Bulletin of Urooncology,  19:85-91, 2020. DOI: 10.4274/uob.galenos.2019.1432
  97. İzol, F. Gokalp.’’Testis Tümörleri-Epidemiyoloji’’ Kanser Gündem Dergisi Vol. 8/2, Mayıs 2020
  98. Deger M, Surmelioglu O, Kuleci S, Izol V, Akdogan N, Dagkiran M, Tanrisever I, Aridogan IA. Comparison of the Effect of Continuous Positive Airway Pressure and Surgical Treatment of Obstructive Sleep Apnea Syndrome on Nocturia. J Urol Surg 2021;8:106-110.

Detaylar

Uzmanlık Alanı
Üroloji ve Üro onkoloji tecrübesi ile sunduğu hizmetlerProstat endokopik cerrahisiProstat lazer tedavisiProstat Holep tedavisiBöbrek mesane ve prostat kanseri açık ve kapalı (Laparoskopik-Endoskopik) cerrahisi
Mezuniyet
Çukurova Üniversitesi Tıp Fakültesi
Şehir:
Adana
Telefon:
+90 322 999 44 04
Email:
info@remedacademy.com
+90 322 999 44 04
info@remedacademy.com

Socials